Search
ATP synthase subunit c
go.drugbank.com/bio_entities/BE0004748TargetMycobacterium tuberculosisF(1)F(0) ATP synthase produces ATP from ADP in the presence of a proton or sodium gradient. … F-type ATPases consist of two structural domains, F(1) containing the extramembraneous catalytic core and F(0) containing the membrane proton channel, linked together by a central stalk and a peripheral
Synonyms: ATP synthase F(0) sector subunit cATP synthase subunit c, sodium ion specific
go.drugbank.com/bio_entities/BE0001846TargetPropionigenium modestumF(1)F(0) ATP synthase produces ATP from ADP in the presence of a proton or sodium gradient. … F-type ATPases consist of two structural domains, F(1) containing the extramembraneous catalytic core and F(0) containing the membrane sodium channel, linked together by a central stalk and a peripheral
Synonyms: ATP synthase F(0) sector subunit cAmino acid transporter heavy chain SLC3A1
go.drugbank.com/bio_entities/BE0001130TransporterHumansSLC7A9-SLC3A1 transporter has system b(0,+)-like activity with high affinity for extracellular cationic amino acids and L-cystine and lower affinity for intracellular neutral amino acids.
Synonyms: b(0,+)-type amino acid transporter-related heavy chainATP synthase subunit b
go.drugbank.com/bio_entities/BE0002030TargetEscherichia coli (strain K12)F(1)F(0) ATP synthase produces ATP from ADP in the presence of a proton or sodium gradient. … F-type ATPases consist of two structural domains, F(1) containing the extramembraneous catalytic core and F(0) containing the membrane proton channel, linked together by a central stalk and a peripheral
Synonyms: ATP synthase F(0) sector subunit bArbutamine
go.drugbank.com/drugs/DB01102ApprovedArbutamine, administered through a closed-loop, computer-controlled drug-delivery system, is indicated to elicit acute cardiovascular responses, similar to those produced by exercise, in order to aid in
Categories: Adrenergic beta-1 Receptor Agonists, Adrenergic beta-2 Receptor AgonistsAdinazolam
go.drugbank.com/drugs/DB00546ExperimentalAdinazolam was first developed to enhance the antidepressant effects of [alprazolam]. It has never been approved by the FDA for clinical use. … Adinazolam (Deracyn®) is a benzodiazepine derivative with anxiolytic, anticonvulsant, sedative, and antidepressant properties.
Categories: Cytochrome P-450 Substrates, Heterocyclic Compounds, 2-RingSynonyms: 8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepineInsulin icodec
go.drugbank.com/drugs/DB16693ApprovedInvestigational[L50758,A263818] Insulin icodec was approved by Health Canada in March 2024 for the treatment of adult patients with type 1 or 2 diabetes mellitus,[L50758] and was subsequently approved by the EMA in … It is a re-engineered version of the ultra long-acting oral basal insulin OI338, with several modifications introduced to significantly extend the half-life.
Metabolism and Physiological Effects of Orotic acid
smpdb.ca/view/SMP0124870MetabolicOrotic acid (orotate) is classified as a pyrimidinemonocarboxylic acid. Most urinary orotic acid is synthesized in the body, where it arises as an intermediate in the pathway for the synthesis of pyrimidine nucleotides. It originates fro...
Enzymes: Neutral amino acid transporter B(0)Metallothionein
go.drugbank.com/bio_entities/BE0008688CarrierTargetHumansZinc-dependent transcriptional regulator of cellular adaption to conditions of exposure to heavy metals (PubMed:8065932). Binds to metal responsive elements (MRE) in promoters and activates the transcription of metallothionein genes like...
Synonyms: MT-0, Metallothionein-0Panic Disorder
go.drugbank.com/conditions/DBCOND0006063